| 000 | 01724 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517184854.0 | ||
| 264 | 0 | _c20171129 | |
| 008 | 201711s 0 0 eng d | ||
| 022 | _a1097-4164 | ||
| 024 | 7 |
_a10.1016/j.molcel.2017.11.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrouwer, Jason M | |
| 245 | 0 | 0 |
_aConversion of Bim-BH3 from Activator to Inhibitor of Bak through Structure-Based Design. _h[electronic resource] |
| 260 |
_bMolecular cell _cNov 2017 |
||
| 300 |
_a659-672.e9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBcl-2-Like Protein 11 _xchemistry |
| 650 | 0 | 4 | _aCell Line, Transformed |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMitochondria _xgenetics |
| 650 | 0 | 4 |
_aPeptides _xchemistry |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_abcl-2 Homologous Antagonist-Killer Protein _xchemistry |
| 700 | 1 | _aLan, Ping | |
| 700 | 1 | _aCowan, Angus D | |
| 700 | 1 | _aBernardini, Jonathan P | |
| 700 | 1 | _aBirkinshaw, Richard W | |
| 700 | 1 | _avan Delft, Mark F | |
| 700 | 1 | _aSleebs, Brad E | |
| 700 | 1 | _aRobin, Adeline Y | |
| 700 | 1 | _aWardak, Ahmad | |
| 700 | 1 | _aTan, Iris K | |
| 700 | 1 | _aReljic, Boris | |
| 700 | 1 | _aLee, Erinna F | |
| 700 | 1 | _aFairlie, W Douglas | |
| 700 | 1 | _aCall, Melissa J | |
| 700 | 1 | _aSmith, Brian J | |
| 700 | 1 | _aDewson, Grant | |
| 700 | 1 | _aLessene, Guillaume | |
| 700 | 1 | _aColman, Peter M | |
| 700 | 1 | _aCzabotar, Peter E | |
| 773 | 0 |
_tMolecular cell _gvol. 68 _gno. 4 _gp. 659-672.e9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.molcel.2017.11.001 _zAvailable from publisher's website |
| 999 |
_c27799694 _d27799694 |
||